Dark

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jun 16, 2025 3:53:49 PM EDT

7.24USD-0.753%(-0.06)20,967

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 17, 2025 8:44:30 AM EDT

7.20USD-0.621%(+7.20)103

After-hours

Jun 17, 2025 4:45:30 PM EDT

7.03USD0.000%(+7.03)310

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

5.69M

Industry

Biotechnology

Last Split

May 15, 20251for28reverse

RNAZ Stats

Avg. Vol. 10 Day

33,556

Avg. Vol. 30 Day

75,143

Employees

Market Cap

5,693,618

Shares Out.

833,619

On/Off Exchange

38%/62%

6 Month Beta

1.44

1 Year Beta

1.34

2 Year Beta

1.59

3 Year Beta

1.09

52 Week Low

6.15

52 Week High

1,113.14

SMA50

9.26

SMA200

195.97

1 Week

-7.33%

1 Month

-16.30%

3 Month

-68.73%

6 Month

-96.14%

1 Year

-99.35%

2 Year

-99.99%

5 Year

-100.00%

Profile

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

RNAZ Stock Summary

TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $7.24, and today's volume is 20,967. RNAZ is down -0.753% today. The 30 day average volume is 75,143. RNAZ market cap is 5.69M with 833,619 shares outstanding.

.dark-mode .XJ8bNJ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .XJ8bNJ{ color: #333333; background-color: white; border: 2px solid #333333; }RNAZTransCode Therapeutics, Inc. Common Stockstock NASDAQ

RNAZ Stock Summary

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ